Position in IMTX
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$102,173,207
-$6,853,081 QoQ
Shares Held
10,383,456
0.0% QoQ
Ownership
7.60%
of shares outstanding
% of Portfolio
2.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $4,570,707,559 across 67 Biotechnology names. IMTX ranks #13 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $655,974,329 | |
| 2 | CELC |
Celcuity Inc.
|
3,127,200 | $356,938,608 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,531,421 | $350,281,925 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
8,285,461 | $229,507,269 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
5,258,903 | $208,883,627 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,373,795 | $206,448,951 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
3,783,225 | $190,825,869 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,580,505 | $161,922,737 |
All Filings in IMTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $102,173,207 | 10,383,456 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $109,026,288 | 10,383,456 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $79,947,045 | 9,383,456 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $50,482,993 | 9,383,456 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,319,386 | 9,383,456 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $66,716,372 | 9,383,456 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $92,263,074 | 8,086,159 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $93,961,167 | 8,086,159 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $48,161,118 | 4,582,409 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $36,765,495 | 3,491,500 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $40,431,570 | 3,491,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $40,291,910 | 3,491,500 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $24,091,350 | 3,491,500 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $30,410,965 | 3,491,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,000,000 | 2,500,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,775,000 | 2,500,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,975,000 | 2,500,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $33,600,000 | 2,500,000 | Shares | Sole | 2022-05-04 | |
| 2021-09-30 | $32,500,000 | 2,500,000 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $29,025,000 | 2,500,000 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $28,025,000 | 2,500,000 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $26,975,000 | 2,500,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $26,525,000 | 2,500,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||